Catheter Precision, Inc. (VTAK)
NYSE · Healthcare
Catheter Precision, Inc. Shareholder Equity 2017–2025
Catheter Precision, Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Catheter Precision, Inc. shareholder equity as of December 31, 2025: 7.1M, a 40.00% decrease year-over-year.
- Catheter Precision, Inc. shareholder equity for 2025 were 7.1M, a 40.00% decrease from 2024.
- Catheter Precision, Inc. shareholder equity for 2024 were 11.8M, a 44.52% decrease from 2023.
- Catheter Precision, Inc. shareholder equity for 2023 were 21.2M, a 128.87% increase from 2022.
- Catheter Precision, Inc. shareholder equity for 2022 were 9.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Catheter Precision, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $12 |
| 2023 | $21 |
| 2022 | $9 |
| 2021 | $14 |
| 2020 | $21 |
| 2019 | $33 |
| 2018 | $67 |
| 2017 | $-8 |
Catheter Precision, Inc. Shareholder Equity — FAQ
Catheter Precision, Inc. (VTAK) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VTAK's shareholder equity history?
The chart and table above show Catheter Precision, Inc.'s shareholder equity by year and by quarter, including the growth rate.